ORG Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$23.8K Buy
95
+19
+25% +$5.05K ﹤0.01% 760
2025
Q3
$21.8K Buy
76
+5
+7% +$1.34K ﹤0.01% 780
2025
Q2
$18.8K Sell
71
-2,767
-97% -$674K ﹤0.01% 774
2025
Q1
$660K Buy
2,838
+540
+23% +$131K 0.16% 118
2024
Q4
$527K Buy
+2,298
New +$527K 0.07% 179
2023
Q4
Sell
-14
Closed -$2.81K 1256
2023
Q3
$2.81K Sell
14
-1,901
-99% -$401K ﹤0.01% 1030
2023
Q2
$391K Buy
+1,915
New +$371K 0.06% 260

Other funds holding LH

ORG Partners's LH Position: Q4 2025 in Review

ORG Partners increased its Labcorp (LH) stake by 25% in Q4 2025, buying an estimated $5.05K and bringing the position to 95 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #760.

ORG Partners first reported a position in LH in Q2 2023 and has held it in 7 quarters since. The position peaked at $660K in Q1 2025. 1,027 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • ORG Partners held 95 shares of Labcorp worth $23.8K as of Q4 2025.
  • ORG Partners bought 19 Labcorp shares in Q4 2025, an estimated $5.05K.
  • Labcorp made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #760 holding.
  • ORG Partners first reported a position in Labcorp in Q2 2023 and has held it in 7 quarters since.
  • ORG Partners's Labcorp position peaked at $660K in Q1 2025.
  • 1,027 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.